Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


04.03.2019

1 Am J Med Genet B Neuropsychiatr Genet
1 Br J Psychiatry
2 Neuropsychopharmacology
3 Neurosci Lett
2 PLoS One
1 Proc Natl Acad Sci U S A
5 Psychiatry Res
7 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Med Genet B Neuropsychiatr Genet

  1. HAROLD D, Connolly S, Riley BP, Kendler KS, et al
    Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet. 2019 Feb 23. doi: 10.1002/ajmg.b.32716.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  2. ZHUO C, Zhuang H, Gao X, Triplett PT, et al
    Lung cancer incidence in patients with schizophrenia: meta-analysis.
    Br J Psychiatry. 2019 Feb 26:1-8. doi: 10.1192/bjp.2019.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  3. BITTER I, Lieberman JA, Gaudoux F, Sokoloff P, et al
    Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia.
    Neuropsychopharmacology. 2019 Mar 1. pii: 10.1038/s41386-019-0355.
    PubMed     Text format     Abstract available

  4. KRUIPER C, Glenthoj BY, Oranje B
    Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication.
    Neuropsychopharmacology. 2019 Feb 23. pii: 10.1038/s41386-019-0351.
    PubMed     Text format     Abstract available


    Neurosci Lett

  5. FANNI D, Gerosa C, Rais M, Ravarino A, et al
    The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming.
    Neurosci Lett. 2018;669:75-82.
    PubMed     Text format     Abstract available

  6. MURRU A, Carpiniello B
    Duration of untreated illness as a key to early intervention in schizophrenia: A review.
    Neurosci Lett. 2018;669:59-67.
    PubMed     Text format     Abstract available

  7. SPANIEL F, Bakstein E, Anyz J, Hlinka J, et al
    Relapse in schizophrenia: Definitively not a bolt from the blue.
    Neurosci Lett. 2018;669:68-74.
    PubMed     Text format     Abstract available


    PLoS One

  8. MARTIN EA, Castro MK, Li LY, Urban EJ, et al
    Emotional response in schizophrenia to the "36 questions that lead to love": Predicted and experienced emotions regarding a live social interaction.
    PLoS One. 2019;14:e0212069.
    PubMed     Text format     Abstract available

  9. DREWS HJ, Wiesner CD, Bethke-Jaenicke C, Weinhold SL, et al
    Slow-wave sleep predicts long-term social functioning in severe mental illness.
    PLoS One. 2018;13:e0202198.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  10. LAINSCSEK C, Sampson AL, Kim R, Thomas ML, et al
    Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia.
    Proc Natl Acad Sci U S A. 2019;116:3847-3852.
    PubMed     Text format     Abstract available


    Psychiatry Res

  11. DEL RE EC, Bouix S, Fitzsimmons J, Blokland GAM, et al
    Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology.
    Psychiatry Res. 2019 Feb 18. pii: S0165-1781(19)30342.
    PubMed     Text format     Abstract available

  12. CORRELL CU, Stanford AD, Claxton A, Du Y, et al
    Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study.
    Psychiatry Res. 2019;274:176-181.
    PubMed     Text format     Abstract available

  13. KALINOWSKA S, Trzesniowska-Drukala B, Safranow K, Pelka-Wysiecka J, et al
    Association between thyroid function and metabolic syndrome in male and female schizophrenia patients.
    Psychiatry Res. 2019;274:167-175.
    PubMed     Text format     Abstract available

  14. LIU Y, Wang G, Jin H, Lyu H, et al
    Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients.
    Psychiatry Res. 2019;274:235-242.
    PubMed     Text format     Abstract available

  15. HWANG DK, Nam M, Lee YG
    The effect of cognitive behavioral therapy for insomnia in schizophrenia patients with sleep Disturbance: A non-randomized, assessor-blind trial.
    Psychiatry Res. 2019;274:182-188.
    PubMed     Text format     Abstract available


    Schizophr Res

  16. KOSHIYAMA D, Kirihara K, Tada M, Nagai T, et al
    Gamma-band auditory steady-state response is associated with plasma levels of d-serine in schizophrenia: An exploratory study.
    Schizophr Res. 2019 Feb 25. pii: S0920-9964(19)30072.
    PubMed     Text format    

  17. MENNIGEN E, Jiang W, Calhoun VD, van Erp TGM, et al
    Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia.
    Schizophr Res. 2019 Feb 25. pii: S0920-9964(19)30070.
    PubMed     Text format     Abstract available

  18. AUKST MARGETIC B, Peitl V, Vukasovic I, Karlovic D, et al
    Neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: Preliminary results.
    Schizophr Res. 2019 Feb 21. pii: S0920-9964(19)30067.
    PubMed     Text format    

  19. SEVERAID KB, Osborne KJ, Mittal VA
    Implications of religious and spiritual practices for youth at clinical high risk for psychosis.
    Schizophr Res. 2019 Feb 21. pii: S0920-9964(19)30035.
    PubMed     Text format    

  20. MARGETIC B
    Comments on "Distinctive profiles of traits predisposing to violence in schizophrenia and in the general population".
    Schizophr Res. 2019 Feb 21. pii: S0920-9964(19)30068.
    PubMed     Text format    

  21. KIM S, Lee SH, Bang M
    Double-sidedness of "laughing gas" on the N-methyl-d-aspartate receptor: A case report of acute psychosis associated with nitrous oxide-induced hyperhomocysteinemia.
    Schizophr Res. 2019 Feb 19. pii: S0920-9964(19)30066.
    PubMed     Text format    

  22. TANG Y, Wang J, Zhang T, Xu L, et al
    P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature.
    Schizophr Res. 2019 Feb 25. pii: S0920-9964(19)30074.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: